Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.

MLA

Xu, Congwang, et al. “Genetically Modified Mesenchymal Stromal Cells: A Cell-Based Therapy Offering More Efficient Repair after Myocardial Infarction.” Stem Cell Research & Therapy, vol. 15, no. 1, Sept. 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13287-024-03942-7.

APA

Xu, C., Xie, Y., & Wang, B. (2024). Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction. Stem Cell Research & Therapy, 15(1), 1–18. https://doi.org/10.1186/s13287-024-03942-7

Chicago

Xu, Congwang, Yuanyuan Xie, and Bin Wang. 2024. “Genetically Modified Mesenchymal Stromal Cells: A Cell-Based Therapy Offering More Efficient Repair after Myocardial Infarction.” Stem Cell Research & Therapy 15 (1): 1–18. doi:10.1186/s13287-024-03942-7.